Suggestions
Fiona Watt
Executive Chair at Medical Research Council
Fiona Watt is a renowned British scientist who has made significant contributions to the field of stem cell biology.1 Born on March 28, 1956, in Edinburgh, Scotland, Watt has had a distinguished career spanning several decades.1
Education and Early Career
Watt obtained her Bachelor's and Master's degrees from the University of Cambridge, followed by a PhD from the University of Oxford in 1979.12 She then completed a postdoctoral fellowship at the Massachusetts Institute of Technology (MIT).14
Research Contributions
Watt's research has primarily focused on elucidating how the epidermis, the outer covering of mammalian skin, is maintained through stem cell self-renewal and differentiation.1 She pioneered the identification of stem cell populations and their regulatory mechanisms, making significant discoveries in areas such as:
- Identifying integrin as the first marker for isolating epidermal stem cells1
- Demonstrating the importance of the extracellular matrix in the stem cell niche1
- Pioneering single-cell gene expression profiling in epidermal stem cells1
- Uncovering new mechanisms of cancer formation and progression1
Leadership Roles
Throughout her career, Watt has held several prestigious leadership positions:
- Director of the Centre for Stem Cells & Regenerative Medicine at King's College London (2012-2022)23
- Executive Chair of the Medical Research Council (MRC) (2018-2022)45
- Current Director of the European Molecular Biology Organization (EMBO) (since 2022)56
Awards and Honors
Watt's contributions to science have been widely recognized. She is a:
- Fellow of the Royal Society (FRS)1
- Fellow of the Academy of Medical Sciences (FMedSci)1
- Foreign Associate of the National Academy of Sciences14
She has also received numerous awards, including the FEBS/EMBO Women in Science Award in 2016.1
Recent Developments
In 2021, Watt faced allegations of bullying, which led to an investigation by UK Research and Innovation (UKRI).7 She acknowledged the findings, offered apologies to those affected, and undertook a personal improvement plan.78 Despite this, Watt continued in her role as MRC Executive Chair until early 2022, when she took up her new position as director of EMBO.56

